These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1990625)

  • 1. Chronic vascular rejection in an inbred rat cardiac model.
    Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):613-4. PubMed ID: 1990625
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenetic studies in a rat cardiac model of chronic vascular rejection.
    Forbes RD; Zheng SX; Gomersall M; al-Saffar M; Prud'homme GJ; Guttmann RD
    Transplant Proc; 1995 Jun; 27(3):2080. PubMed ID: 7792892
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
    Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R
    Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cyclosporine on chronic vascular rejection in an inbred rat cardiac model.
    Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):530-1. PubMed ID: 8438402
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously.
    Lowry RP; Takeuchi T; Cremisi H; Konieczny B; Someren A
    Transplant Proc; 1993 Apr; 25(2):2103-5. PubMed ID: 8470286
    [No Abstract]   [Full Text] [Related]  

  • 6. Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival.
    Slakey D; Roza A; Pieper G; Johnson C; Adams M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):610-1. PubMed ID: 8438434
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine and the reversibility of chronic vascular rejection.
    Guttmann RD; Forbes RD; Zheng S; Busque S
    Transplant Proc; 1994 Oct; 26(5):2564-6. PubMed ID: 7940792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat strain differences in complement activity correlate with hyperacute rejection of guinea pig cardiac xenografts.
    Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
    Transplant Proc; 1993 Oct; 25(5):2848-9. PubMed ID: 8212257
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence that recipient CD8+ T cell depletion does not alter development of chronic vascular rejection in a rat heart allograft model.
    Forbes RD; Zheng SX; Gomersall M; al-Saffar M; Guttmann RD
    Transplantation; 1994 Apr; 57(8):1238-46. PubMed ID: 8178351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
    Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
    [No Abstract]   [Full Text] [Related]  

  • 12. Retransplantation and reversibility of chronic vascular rejection.
    Zheng SX; Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1997; 29(1-2):1541. PubMed ID: 9123417
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary disease in patients after heart transplantation].
    Chomette G
    Ann Cardiol Angeiol (Paris); 1991 Dec; 40(10):593-7. PubMed ID: 1781633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts.
    Adams DH; Karnovsky MJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):437-9. PubMed ID: 2650168
    [No Abstract]   [Full Text] [Related]  

  • 15. Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and -independent factors.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Jun; 27(3):2077-9. PubMed ID: 7792891
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract]   [Full Text] [Related]  

  • 17. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic approaches in chronic rejection and cardiac vascularization reinjury.
    Häyry P
    Transplant Proc; 1996 Dec; 28(6):3435-6. PubMed ID: 8962339
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts.
    Koskinen P; Lemström K; Bruning H; Daemen M; Bruggeman C; Häyry P
    Transplant Proc; 1995 Feb; 27(1):574-5. PubMed ID: 7879104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.